Anti-inflammatory activities of aller-7, a novel polyherbal formulation for allergic rhinitis

International Journal of Tissue Reactions

Volumn 26, Issue 1-2, 2004, Pages 43-51

  Pratibha, N ^a   Saxena, V S ^a   Amit, A ^a   D'Souza, P ^a   Bagchi, M ^b   Bagchi, Debsis ^b  

^a Natural Remedies Pvt Ltd   (India)

^b CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBIZIA LEBBECK EXTRACT; ALLER 7; ANTIINFLAMMATORY AGENT; BLACK PEPPER EXTRACT; CARRAGEENAN; COMPOUND 48-80; EMBLICA OFFICINALIS EXTRACT; FREUND ADJUVANT; GINGER EXTRACT; IBUPROFEN; KETOTIFEN; OVOMUCOID; PIPER LONGUM EXTRACT; PLANT EXTRACT; PREDNISOLONE; TERMINALIA BELLERICA EXTRACT; TERMINALIA CHEBULA EXTRACT; TRYPSIN INHIBITOR; UNCLASSIFIED DRUG;

ALBIZIA LEBBECK; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; BARK; BLACK PEPPER; CONTROLLED STUDY; DRUG EFFICACY; EMBLICA OFFICINALIS; FRUIT; GINGER; IC 50; IN VIVO STUDY; MEDICINAL PLANT; MOUSE; MOUSE STRAIN; NONHUMAN; PAW EDEMA; PIPER LONGUM; RHIZOME; SPICE; TERMINALIA; TERMINALIA BELLERICA; TERMINALIA CHEBULA;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; FEMALE; HUMANS; MALE; MICE; MICE, INBRED BALB C; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; RATS; RATS, WISTAR; RHINITIS, ALLERGIC, PERENNIAL; TRYPSIN;

ALBIZIA; ALBIZIA LEBBECK; PHYLLANTHUS EMBLICA; PIPER LONGUM; PIPER NIGRUM; TERMINALIA; TERMINALIA CHEBULA; ZINGIBER; ZINGIBER OFFICINALE;

EID: 8844271723     PISSN: 02500868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Salib R.J., Drake-Lee A., Howarth P.H. Allergic rhinitis: Past, present and the future. Clin. Otolaryngol., 28, 291, 2003.
2. May J.R., Feger T.A., Guill M.F. "Allergic Rhinitis." In: Dipiro J.T., Talbert R.L., Yee G.C., et al. (Eds.). " Pharmacotherapy: A Pathophysiologic Approach," Appleton Lange, Stamford, 1997, p. 1801, 1997.
3. Taylor M.A., Reilly D., Jones L.R.H., et al. Randomized controlled trial of homoeopathy versus placebo in perennial allergic rhinitis with overview of four trial series. BMJ, 321, 471, 2000.
4. Wanner A. Clinical aspects of mucociliary transport. Am. Rev. Respir. Dis., 116, 73, 1977.
5. "Management of Allergic Rhinitis and Its Impact on Asthma. A Pocket Guide." Astrazeneca in collaboration with WHO, Geneva, 2001, pp. 1-23.
6. Tarnasky P.R., Van Arsdel P.P. Jr. Antihistamine therapy in allergic rhinitis. J. Fam. Pract., 30, 71, 1990.
7. Meltzer E.O. Antihistamine- and decongestant-induced performance decrements. J. Occup. Med., 32, 327, 1990.
8. Agnew J.E., Little F., Pavia D., et al. Mucus clearance from the airways in chronic bronchitis - Smokers and ex-smokers. Bull Eur. Physiopathol. Respir., 18, 473, 1982.
9. Lourenco R.V., Loddenkemper R., Carton R.W. Patterns of distribution and clearance of aerosols in patients with bronchiectasis Am. Rev. Respir. Dis., 106, 857, 1972.
10. Amit A., Saxena V.S., Pratibha N., et al. Safety of a novel botanical extract formula for ameliorating allergic rhinitis. Toxicol. Mech. Meth., 13, 253, 2003.
11. Amit A., Saxena V.S., Pratibha N., et al. Mast cell stabilization, lipoxygenase inhibition, hyaluronidase inhibition, antihistaminic and antispasmodic activities of Aller-7, a novel botanical formulation for allergic rhinitis. Drugs Exptl. Clin. Res., 29, 107, 2003.
12. Chantry D., Burgess L.E. Chemokines in allergy. Curr. Drug Targets Inflamm. Allergy, 1, 109, 2002.
13. Heyliger S.O., Mazzio E.A., Soliman K.F. The anti-inflammatory effects of quinolinic acid in the rat. Life Sci., 64, 1177, 1999.
14. Banks B.E., Dempsey C.E., Vernon C.A., et al. Anti-inflammatory activity of bee venom peptide 401 (mast cell degranulating peptide) and compound 48/80 results from mast cell degranulation in vivo. Br J. Pharmacol., 99, 350, 1990.
15. Khalaj A., Abdollahi M., Kebriaeezadeh A., et al. The antinociceptive and anti-inflammatory activities and lack of ulcerogenicity of a benzodioxin-4-one and its analog benzoxazine as cyclic acetal-like derivatives of salicylic acid and salicylamide in mice and rats. Int. J. Pharmacol., 34, 184, 2002.
16. Dai Y., Chan Y.P., Chu L.M., et al. Antiallergic and anti-inflammatory properties of the ethanolic extract from Gleditsia sinesis. Biol. Pharm. Bull., 25, 1179, 2002.
17. Kim M.S., Na H.J., Han S.W., et al. Forsythia fructus inhibits the mast-cell-mediated allergic inflammatory reactions. Inflammation, 27, 129, 2003.
18. Devillier P. Pharmacology of non-steroidal anti-inflammatory drugs and ENT pathology. Presse Med., 30(39-40 Pt 2), 70, 2001.
19. Van Cauwenberge P. Recent development of anti-allergic drugs. Rhinol. Suppl., 14, 67, 1992.
20. Bellioni P., Pezzuto R.W. Medical therapy of allergic rhinitis. Recenti. Prog. Med., 80, 393, 1989.
21. Nair A.M., Tamhankar C.P., Saraf M.N. Studies on the mast cell stabilizing activity of Vitex negundo Linn., Indian Drugs, 31 277, 1995.
22. Vogel G.H., Vogel W.H. Drug discovery and evaluation - Pharmacological assays. Springer Verlag, Berlin, 1997, p. 406.
23. Winter C.A., Risley E.A., Nuss G.W. Carrageenan-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc. Soc. Exp. Biol. Med., 111, 544, 1962.
24. Lewis D.A. Anti-inflammatory drugs from plant and marine sources. Birkhauser Verlag, Berlin, 1989, p. 65.
25. Pearson C.M. Rheumatic manifestations of polymyositis and dermatomyositis. Arthritis Rheum., 2, 127, 1959.
26. Cannell R.J., Kelton S.J., Owsianka A.M., Walker J.M. Results of a large scale screen of Microalgae for the production of protease inhibitors. Planta Med., 54, 10, 1988.
27. Lineweaver H., urry C.W. Identification of the trypsin inhibitor of egg white with Ovomucoid. J. Biol. Chem., 171, 565, 1947.
28. Serafin W.E. "Drugs Used in the Treatment of Asthma." In: Hardman J.G., Limbird L.E., Molinoff P.B., et al. (Eds.). "The Pharmacological Basis of Therapeutics." McGraw-Hill, New York, 1996, p. 659.
29. Insel P.A. "Analgesic-Antipyretic and Anti-inflammary Agents and Drugs Employed in the Treatment of Gout." In: Hardman J.G., Limbird L.E., Molinoff PB., et al. (Eds.). "The Pharmacological Basis of Therapeutics." McGraw-Hill, New York, 1996, p. 617.
30. Babe K.S., Serafin W.E. "Histamine Bradykinin and Their Antagonists." In: Hardman J.G., Limbird L.E., Molinoff P.B., et al. (Eds.). "The Pharmacological Basis of Therapeutics." McGraw-Hill, New York, 1996, p. 581.
31. Willsie S.K. Improved strategies and new treatment options for Allergic rhinitis. J. Am. Osteopathol. Assoc., 102, S7, 2002.
32. International Rhinitis Management Working Group. International consensus report on the diagnosis and management of rhinitis. Allergy, 49, 1, 1994.
33. Morris E.C. Pharmacotherapy of allergic disease. Prim. Care, 14, 605, 1987.
34. Albegger K. The symptomatic therapy of allergic rhinitis Laryngorhinootologie, 69, 613, 1990.